REG - Reckitt Benckiser Gp - Commencement of Third Tranche of Share Buyback

Reckitt BenckiserAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nRSI7541Va&default-theme=true

RNS Number : 7541V  Reckitt Benckiser Group PLC  09 March 2026

9 March 2026

 

RECKITT BENCKISER GROUP PLC

 

2025 SHARE BUYBACK PROGRAMME - THIRD TRANCHE

 

On 24 July 2025, Reckitt Benckiser Group plc ("Reckitt" or the "Company")
announced a £1 billion share buyback programme (the "Programme") to complete
over the then following 12 months, the purpose of which is to increase returns
to shareholders and to reduce the share capital of Reckitt. On 28 July 2025,
Reckitt announced the details of a first tranche of the Programme to return up
to £250 million of capital to shareholders (the "First Tranche"). On 22
October 2025 Reckitt announced commencement of the second tranche of this
Programme to return up to a further £250 million of capital to shareholders
(the "Second Tranche") which completed on 30 January 2026 with £206 million
having been returned under this tranche.

 

Further to the Full Year Results Announcement on 5 March 2026, Reckitt today
announces its intention to commence the third tranche of the Programme (the
"Third Tranche") which will return up to a further £540 million of capital to
shareholders, to begin on 9 March 2026 and which is expected to end no later
than 27 July 2026. All shares repurchased under the Third Tranche will be held
in Treasury.

 

Reckitt announces that it has entered into an agreement with Deutsche Bank AG,
London Branch under which it has issued an instruction to Deutsche Bank AG,
London Branch to manage the Third Tranche of the Programme. Deutsche Bank AG,
London Branch will, acting as riskless principal, purchase Ordinary Shares for
an aggregate purchase price of no greater than £540 million and will
simultaneously sell such Ordinary Shares on to the Company.

 

Any purchase of Ordinary Shares in relation to this announcement will be
carried out on the London Stock Exchange and Multilateral Trading Facilities,
as defined by the Directive 2014/65/EU on markets in financial instruments
(including the delegated and implementing acts adopted under it) as
implemented, retained, amended, extended, re-enacted or otherwise given effect
in the United Kingdom from 1 January 2021 and as amended or supplemented in
the United Kingdom thereafter, and executed in accordance with the Listing
Rules and Reckitt's general authority to make market purchases of Ordinary
Shares. The shares will be purchased in accordance with the price and volume
conditions set out in the Commission Delegated Regulation (EU) 2016/1052 of 8
March 2016 supplementing Regulation (EU) No 596/2014 of the European
Parliament and of the Council with regard to regulatory technical standards
for the conditions applicable to buyback programmes and stabilisation measures
as implemented, retained, amended, extended, re-enacted or otherwise given
effect in the United Kingdom from 1 January 2021 and as amended or
supplemented in the United Kingdom thereafter.

 

Reckitt will announce any market repurchase of Ordinary Shares no later than
7.30 a.m. on the business day following the calendar day on which the
repurchase occurred or in accordance with the timings specified in the Listing
Rules. To the extent permitted by law, Ordinary Shares purchased under the
Third Tranche of the Programme will be held in Treasury. For the avoidance of
doubt, no repurchases will be made in respect of the Company's American
Depository Receipts.

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

For further Information:

 

Catheryn O'Rourke                  Tel +44 (0) 1753 217 800

Company Secretary

 

Nick Ashworth
 
Tel. +44 (0) 7408 812350

Investor Relations Director

 

 

About Reckitt*:

 

We make the products people trust to care for the ones they love. We are home
to some of the world's best-loved consumer health and hygiene brands,
including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen,
Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By
creating innovative, science-backed solutions, we support people every day to
live healthier lives.

 

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. This commitment goes beyond the products we make. Through our
actions, we expand access to healthcare, education and economic opportunities.
We support the planet by reducing waste, conserving resources and driving
sustainable innovation.

 

We believe good health starts at home. With every action we take, we strive to
make our consumers' lives easier, cleaner and healthier, to strengthen
communities and to create a more sustainable future.

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBRGDXUUGDGLL



            Copyright 2019 Regulatory News Service, all rights reserved